InChI=1S/C40H43N7O7S/c1- 24- 21- 42- 33(22- 41- 24) 35(48) 43- 32- 16- 6- 4- 2- 3- 5- 11- 25- 20- 40(25,39(51) 46- 55(52,53) 27- 17- 18- 27) 45- 36(49) 34- 19- 26(23- 47(34) 38(32) 50) 54- 37- 30- 14- 8- 7- 12- 28(30) 29- 13- 9- 10- 15- 31(29) 44- 37/h5,7- 15,21- 22,25- 27,32,34H,2- 4,6,16- 20,23H2,1H3,(H,43,48) (H,45,49) (H,46,51) /b11- 5- /t25- ,26+,32- ,34- ,40+/m0/s1 |
UAUIUKWPKRJZJV-MDJGTQRPSA-N |
Cc1cnc(cn1) C(=O) N[C@H] 1CCCCC\C=C/[C@H] 2C[C@] 2(NC(=O) [C@@H] 2C[C@H] (CN2C1=O) Oc1nc2ccccc2c2ccccc12) C(=O) NS(=O) (=O) C1CC1 |
|
antiviral drug
A substance used in the prophylaxis or therapy of virus diseases.
hepatitis C protease inhibitor
An inhibitor of hepatitis C protease, an enzyme required for production of proteins needed for viral assembly.
|
|
antiviral drug
A substance used in the prophylaxis or therapy of virus diseases.
|
|
View more via ChEBI Ontology
(2R,6S,12Z,13aR,14aR,16aS)- N- (cyclopropanesulfonyl)- 6- [(5- methylpyrazine- 2- carbonyl)amino]- 5,16- dioxo- 2- [(phenanthridin- 6- yl)oxy]- 1,2,3,6,7,8,9,10,11,13a,14,15,16,16a- tetradecahydrocyclopropa[e]pyrrolo[1,2- a][1,4]diazacyclopentadecine- 14a(5H)- carboxamide
|
ABT 450
|
ChemIDplus
|
ABT450
|
ChemIDplus
|
Veruprevir
|
ChemIDplus
|
1216941-48-8
|
CAS Registry Number
|
ChemIDplus
|
1216941-48-8
|
CAS Registry Number
|
KEGG DRUG
|
25644279
|
PubMed citation
|
Europe PMC
|
25646891
|
PubMed citation
|
Europe PMC
|
25680759
|
PubMed citation
|
Europe PMC
|
25706092
|
PubMed citation
|
Europe PMC
|
|